MA26862A1 - Nouveaux esters derivant de (rr,ss)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl) phennyle 2-hydroxybenzoate - Google Patents

Nouveaux esters derivant de (rr,ss)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl) phennyle 2-hydroxybenzoate

Info

Publication number
MA26862A1
MA26862A1 MA26710A MA26710A MA26862A1 MA 26862 A1 MA26862 A1 MA 26862A1 MA 26710 A MA26710 A MA 26710A MA 26710 A MA26710 A MA 26710A MA 26862 A1 MA26862 A1 MA 26862A1
Authority
MA
Morocco
Prior art keywords
hydroxycyclohexyl
esters derived
phennyl
dimethylaminomethyl
hydroxybenzoate
Prior art date
Application number
MA26710A
Other languages
English (en)
Inventor
Mancini Marisabel Mourelle
Ramon Amat Elisabet De
Clotet Huguet
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Publication of MA26862A1 publication Critical patent/MA26862A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

De nouveaux esters dérivant de (RR,SS)-3 (2-diméthyl-aminornéthyl-1-hydroxycyclohexyl) phényle 2-hydi oxybenzoate, analogie au Tramadol, un procédé pour les obtenir et l'utilisation de ces composés pour la production d'un médicament ayant des propriétés analgésiques. Ces nouveaux produits de la formule générale (1) présentent une activité analgésique supérieure à celle de tramadol.
MA26710A 1999-12-30 2002-06-24 Nouveaux esters derivant de (rr,ss)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl) phennyle 2-hydroxybenzoate MA26862A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000060A ES2160534B1 (es) 1999-12-30 1999-12-30 Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.

Publications (1)

Publication Number Publication Date
MA26862A1 true MA26862A1 (fr) 2004-12-20

Family

ID=8491916

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26710A MA26862A1 (fr) 1999-12-30 2002-06-24 Nouveaux esters derivant de (rr,ss)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl) phennyle 2-hydroxybenzoate

Country Status (30)

Country Link
US (1) US6894076B2 (fr)
EP (1) EP1251120B1 (fr)
JP (1) JP2003519208A (fr)
KR (1) KR20020063281A (fr)
CN (1) CN1414946A (fr)
AP (1) AP1234A (fr)
AT (1) ATE284380T1 (fr)
AU (1) AU775918B2 (fr)
BG (1) BG106883A (fr)
BR (1) BR0016882A (fr)
CA (1) CA2395976A1 (fr)
CZ (1) CZ20022189A3 (fr)
DE (1) DE60016631D1 (fr)
EA (1) EA004770B1 (fr)
EE (1) EE200200365A (fr)
ES (1) ES2160534B1 (fr)
HR (1) HRP20020559A2 (fr)
HU (1) HUP0204147A3 (fr)
IL (1) IL150392A0 (fr)
IS (1) IS6440A (fr)
MA (1) MA26862A1 (fr)
MX (1) MXPA02006514A (fr)
NO (1) NO20023098L (fr)
NZ (1) NZ520263A (fr)
OA (1) OA12132A (fr)
PL (1) PL356056A1 (fr)
SK (1) SK9252002A3 (fr)
WO (1) WO2001049650A1 (fr)
YU (1) YU50902A (fr)
ZA (1) ZA200205193B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
CA2713128C (fr) 2008-01-25 2016-04-05 Gruenenthal Gmbh Forme posologique pharmaceutique
AU2009243681B2 (en) 2008-05-09 2013-12-19 Grunenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
US8058469B2 (en) * 2008-11-03 2011-11-15 Sabic Innovative Plastics Ip B.V. Method for making carbamates, ureas and isocyanates
CN102639118B (zh) 2009-07-22 2015-07-29 格吕伦塔尔有限公司 氧化稳定的抗干扰剂型
KR101738369B1 (ko) 2009-07-22 2017-05-22 그뤼넨탈 게엠베하 핫 멜트 압출된 제어 방출 투여형
EP2383255A1 (fr) 2010-04-28 2011-11-02 Lacer, S.A. Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
TWI516286B (zh) 2010-09-02 2016-01-11 歌林達股份有限公司 含陰離子聚合物之抗破碎劑型
BR112013005194A2 (pt) 2010-09-02 2016-05-03 Gruenenthal Gmbh forma de dosagem resistente à violação compreendendo sal inorgânico
EP2530072A1 (fr) 2011-06-03 2012-12-05 Lacer, S.A. Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
BR112014001091A2 (pt) 2011-07-29 2017-02-14 Gruenenthal Gmbh comprimido resistente à adulteração que fornece liberação imediata do fármaco
EA201400172A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
EP2838512B1 (fr) 2012-04-18 2018-08-22 Grünenthal GmbH Forme pharmaceutique inviolable et résistante au basculement de dose
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
EP3003279A1 (fr) 2013-05-29 2016-04-13 Grünenthal GmbH Forme pharmaceutique inviolable contenant une ou plusieurs particules
BR112016000194A8 (pt) 2013-07-12 2019-12-31 Gruenenthal Gmbh forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
EP3073994A1 (fr) 2013-11-26 2016-10-05 Grünenthal GmbH Préparation de composition pharmaceutique en poudre par cryo-broyage
WO2015173195A1 (fr) 2014-05-12 2015-11-19 Grünenthal GmbH Formulation pour capsule à libération immédiate résistant aux manipulations illicites comprenant du tapentadol
WO2016170097A1 (fr) 2015-04-24 2016-10-27 Grünenthal GmbH Forme galénique inviolable avec libération immédiate et résistance à l'extraction par solvant.
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
WO2017063509A1 (fr) 2015-10-15 2017-04-20 江苏恒瑞医药股份有限公司 Dérivé oxa spiro, son procédé de préparation, et ses applications dans des médicaments

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
DE1518663A1 (de) 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US3562589A (en) * 1968-09-09 1971-02-09 Ite Imperial Corp Electrically resetting undervoltage trip for circuit breakers
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
DE19525137C2 (de) 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
GB9924604D0 (en) * 1999-10-18 1999-12-22 European Molecular Biology Lab Embl Genetic switch

Also Published As

Publication number Publication date
US20030100598A1 (en) 2003-05-29
KR20020063281A (ko) 2002-08-01
EE200200365A (et) 2003-10-15
ES2160534B1 (es) 2002-04-16
YU50902A (sh) 2006-01-16
EP1251120A1 (fr) 2002-10-23
MXPA02006514A (es) 2004-07-30
EP1251120B1 (fr) 2004-12-08
CA2395976A1 (fr) 2001-07-12
AP1234A (en) 2003-12-28
BG106883A (en) 2003-05-30
AU2012601A (en) 2001-07-16
CZ20022189A3 (cs) 2003-03-12
IS6440A (is) 2002-06-25
HUP0204147A3 (en) 2003-10-28
EA004770B1 (ru) 2004-08-26
WO2001049650A1 (fr) 2001-07-12
AU775918B2 (en) 2004-08-19
AP2002002571A0 (en) 2002-09-30
SK9252002A3 (en) 2003-04-01
HRP20020559A2 (en) 2004-02-29
NO20023098D0 (no) 2002-06-26
NO20023098L (no) 2002-06-26
PL356056A1 (en) 2004-06-14
DE60016631D1 (de) 2005-01-13
HUP0204147A2 (hu) 2003-04-28
ES2160534A1 (es) 2001-11-01
IL150392A0 (en) 2002-12-01
US6894076B2 (en) 2005-05-17
NZ520263A (en) 2004-07-30
BR0016882A (pt) 2002-11-05
ZA200205193B (en) 2003-06-27
CN1414946A (zh) 2003-04-30
JP2003519208A (ja) 2003-06-17
ATE284380T1 (de) 2004-12-15
OA12132A (en) 2006-05-05
EA200200614A1 (ru) 2002-12-26

Similar Documents

Publication Publication Date Title
MA26862A1 (fr) Nouveaux esters derivant de (rr,ss)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl) phennyle 2-hydroxybenzoate
MA26765A1 (fr) Nouveaux esters derives de composes phenyl-cyclohexyl substitues.
CN101511350A (zh) 二氧代烷与二氧代烯
DZ3030A1 (fr) Procédé et produits intermédiaires pour la préparation de composés anti-cancéreux.
JP2020036617A (ja) カンナビノイド化合物を同時作製する装置及び方法
DZ490A1 (fr) Nouveaux dérivés d'acides aminés bicycliques, procédé pour leur préparation, médicaments contenant ces composés et leur utilisation, nouveaux acides aminés bicycliques comme produits intermédiaires etprocédé pour leur préparation.
CA2206794A1 (fr) Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament
AU2003202585A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
HU215110B (hu) Eljárás szubsztituált taxánszármazékok és hatóanyagként ilyen vegyületeket tartalmazó gyógyszerkészítmények előállítására
US20220089532A1 (en) Benzene derivative
CN1144878C (zh) 制备光学纯的(S)-3-羟基-γ-丁内酯的方法
CA1213892A (fr) Procede de preparation de nouveaux derives de la sulfonyluree
CA2399819C (fr) Procede de separation enzymatique de racemates de derives d'aminomethyl-aryl-cyclohexanol
CA2337269C (fr) Nouveau procede de preparation d'intermediaires de synthese
CN106032381A (zh) 一种咪达唑仑衍生物的工业制造方法
KR101399551B1 (ko) 광학적으로 활성인 사이클로펜텐온의 제조방법 및 그로부터제조된 사이클로펜텐온
KR19980703485A (ko) 에폭시숙신산 유도체
US5326785A (en) Caffeic acid derivatives and pharmaceutical compositions containing the same
Senanayake et al. Rabbit liver esterase-mediated enantioselective synthesis of 2-arylpropanoic acids
KR100402048B1 (ko) 키랄 에스테르의 제조방법
Shi-Hui et al. Synthesis of enantiomerically pure cycloalkenols via combination strategy of enzyme-catalyzed reaction and RCM reaction
WO2005063671A1 (fr) Derives d'ether
CN110698426B (zh) 叔丁醇钾高效催化制备1,3-苯并噻唑衍生物的方法
JP2005053933A (ja) アシル化（ｒ）−アミン類
CN101462971B (zh) 高纯度的用于制备福莫特罗的关键中间体及其制备方法